로딩 중…
지수 로딩 중…
GREEN LIFESCIENCE CO., LTD.
114450· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩1,998-7.71%
2026-06-19
Price Chart
GREEN LIFESCIENCE CO., LTD.-44.81%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 39.96B KRW |
| Revenue | 51.02B KRW |
| Net Income | 729.5M KRW |
| Total Assets | 56.01B KRW |
| Net Assets | 40.04B KRW |
| Employees | 65 |
| Value | |
| P/E | 54.78x |
| P/B | 1.00x |
| PEG | 0.29x |
| P/S | 0.78x |
| EV/EBITDA | 11.96x |
| FCF Yield | -1.24% |
| Profitability | |
| ROE | 1.82% |
| ROA | 1.30% |
| Op. Margin | 5.68% |
| Revenue Growth | 219.16% |
| Earnings Growth | 187.40% |
| Financial Health | |
| Debt Ratio | 139.89% |
| Total Debt | 4.80B KRW |
| FCF | -495.7M KRW |
| Cash | 10.12B KRW |
| Current Ratio | 2.17x |
| Net Debt/EBITDA | -1.83x |
| Dividend | |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -44.81% |
| 1M Return | -33.40% |
| From 52W High | -56.47% |
| 1Y MDD | -50.61% |
| Trading | |
| Volume | 403,108 shares |
| Foreign Own. | 4.79% |
| Per Share | |
| EPS | 151 KRW |
| BPS | 2,019 KRW |
Company Info
Green Life Science, established in 2005 and headquartered in Yeosu-si, Jeollanam-do, is a specialized manufacturer of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, listed on the KOSDAQ market in 2009. The company pioneered the development of EDP-CL, a piperacillin-based antibiotic intermediate, in Korea, supplying it to global pharmaceutical companies, and its synthesis plant was the first in Korea to receive U.S. FDA approval. It produces various APIs and raw material intermediates, including DSC for HIV treatment and antibiotic intermediate AM19, while maintaining a quality management system compliant with cGMP standards.